Journal
Theraputic Advances Respiratory Disease
Publication Date
1-1-2023
Volume
17
First Page
e17534666231165912
Document Type
Open Access Publication
DOI
10.1177/17534666231165912
Rights and Permissions
Astor TL, Goldberg HJ, Snyder LD, Courtwright A, Hachem R, Pena T, Zaffiri L, Criner GJ, Budev MM, Thaniyavarn T, Leonard TB, Bender S, Barakat A, Breeze JL, LaCamera P. Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis. Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231165912. doi: 10.1177/17534666231165912. © The Author(s), 2023. Creative Commons License (CC BY-NC 4.0) This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Recommended Citation
Astor, Todd L.; Goldberg, Hilary J.; Snyder, Laurie D.; Courtwright, Andrew; Hachem, Ramsey; Pena, Tahuanty; Zaffiri, Lorenzo; Criner, Gerard J.; Budev, Marie M.; Thaniyavarn, Tany; Leonard, Thomas B.; Bender, Shaun; Barakat, Aliaa; Breeze, Janis L.; and LaCamera, Peter, "Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis." Theraputic Advances Respiratory Disease. 17, e17534666231165912 (2023).
https://digitalcommons.wustl.edu/oa_4/1883
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
